Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

Treatment usually begins with topical ointments and creams, including steroids designed to thin the scales. It must be done carefully, because injury can cause psoriasis to flare. Suephy Chen ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered biologics.

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

Psoriasis is an autoimmune skin condition that causes itchiness and inflammation. This means that the immune system of the ...

Not a lot of people know about psoriasis which is why several myths and misconceptions about the condition continue to ...

Biologics are more targeted than other psoriasis treatments. They’re also more expensive, and you take them less frequently. Doctors usually prescribe them for moderate to severe psoriasis.

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...